MARKET

NRC

NRC

National Resh Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.56
+0.63
+1.97%
After Hours: 32.56 0 0.00% 16:00 05/20 EDT
OPEN
32.34
PREV CLOSE
31.93
HIGH
32.66
LOW
31.67
VOLUME
31.42K
TURNOVER
0
52 WEEK HIGH
55.67
52 WEEK LOW
30.93
MARKET CAP
820.33M
P/E (TTM)
22.65
1D
5D
1M
3M
1Y
5Y
BRIEF-National Research Corporation Announces Quarterly Dividend And Stock Repurchase Authorization
reuters.com · 1d ago
National Research declares $0.24 dividend
National Research (NASDAQ:NRC) declares $0.24/share quarterly dividend, in line with previous. Forward yield 2.95% Payable July 15; for shareholders of record June 30; ex-div June 29. The Company’s Board of
Seekingalpha · 1d ago
National Research's (NASDAQ:NRC) five-year total shareholder returns outpace the underlying earnings growth
National Research Corporation ( NASDAQ:NRC ) shareholders might be concerned after seeing the share price drop 16% in...
Simply Wall St. · 05/04 12:42
National Research Q1 EPS $0.34 Down From $0.36 YoY, Sales $38.40M Up From $35.46M YoY
National Research (NASDAQ:NRC) reported quarterly earnings of $0.34 per share. This is a 5.56 percent decrease over earnings of $0.36 per share from the same period last year. The company reported $38.40 million in
Benzinga · 05/03 21:13
National Research GAAP EPS of $0.34, revenue of $38.4M
National Research press release (NASDAQ:NRC): Q1 GAAP EPS of $0.34. Revenue of $38.4M (+8.2% Y/Y). Shares +0.24% AH.
Seekingalpha · 05/03 21:13
BRIEF-National Research Corporation Announces First Quarter 2022 Results
reuters.com · 05/03 21:08
National Research Corporation Announces First Quarter 2022 Results
LINCOLN, Neb., May 03, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2022. Q1 2022 financial results compared to Q1 2021: Revenue increased 8% to $38.4 millionOperating in...
GlobeNewswire · 05/03 21:00
-- Earnings Flash (NRC) NATIONAL RESEARCH CORPORATION Posts Q1 Revenue $38.4M
MT Newswires · 05/03 17:13
More
No Data
Learn about the latest financial forecast of NRC. Analyze the recent business situations of National Resh Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
EPS
Actual
Estimate
0.100.190.280.38
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2018
Institutional Holdings
Institutions: 153
Institutional Holdings: 13.38M
% Owned: 53.11%
Shares Outstanding: 25.19M
TypeInstitutionsShares
Increased
49
607.51K
New
18
155.70K
Decreased
24
520.75K
Sold Out
13
54.09K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Business Support Services
+0.33%
Professional & Commercial Services
+1.11%
Key Executives
President/Chief Executive Officer/Director
Michael Hays
Chief Financial Officer/Senior Vice President - Finance/Treasurer/Secretary
Kevin Karas
Chief Operating Officer
Jona Raasch
Other
Helen Hrdy
Lead Director/Independent Director
John Nunnelly
Director
Parul Bhandari
Independent Director
Donald Berwick
Independent Director
Stephen Lockhart
Independent Director
Penny Wheeler
No Data
No Data
About NRC
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare organizations in the United States and Canada. The Company’s purpose is to enable human understanding. Its solutions enable healthcare organizations to understand what matters most to each person they serve. The Company’s portfolio of solutions represents a set of capabilities that individually and collectively provide value to its clients. The Company’s portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. Its clients include integrated health systems, post-acute providers and payer organizations.

Webull offers kinds of National Research Corporation stock information, including NASDAQ:NRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NRC stock methods without spending real money on the virtual paper trading platform.